News & Events

Board of Directors

Bryan Roberts, Ph.D.

Board Member

Bryan Roberts, Ph.D., is a member of the board of directors at Encoded Therapeutics and a partner at Venrock. Bryan has partnered with early-stage entrepreneurs innovating across healthcare and life sciences. In addition to Encoded Therapeutics, Bryan is currently involved with companies across therapeutics, genomics, and health tech, including Aledade, Devoted Health, Element Biosciences, Included Health, Interdict, Kelonia Therapeutics, Lyra Health, Moonlight Bio, Mythic Therapeutics, SmithRx and Suki.ai.

Past investments include 10x Genomics (NASDAQ: TXG), Ariosa Diagnostics (acquired by Roche), athenahealth (NASDAQ: ATHN), Fate Therapeutics (NASDAQ: FATE), Ikaria (acquired by Mallinckrodt), Illumina (NASDAQ: ILMN), Ironwood Pharmaceuticals (NASDAQ: IRWD), Receptos (acquired by Celgene), Sirna Therapeutics (acquired by Merck), and Zeltiq (acquired by Allergan).

He holds a Ph.D. in Chemistry and Chemical Biology from Harvard University. He received his B.A. from Dartmouth College.